COVID-19 pandemic showed in many settings that the private sector has been key to support the fight against the pandemic, bringing resources, skills and capacities to maximize the national response. At the same time, adverse behaviours and opportunistic practices have also been featured by private actors in the health systems. This highlighted the need for a strong governance of the health system as a whole in order to steward all health actors to behave in accordance with national health principles. WHO Country Connector on Private Sector in Health (CCPSH) aims to to support Member states in employing different governance tools for building resilient health systems that would be able to absorb shocks from acute events such as COVID-19 or prolonged health emergencies such as those experienced in fragile and conflict affected states (FCS)
This note explains WHO's work to develop guidance on governance of the private sector in health for emergency response, to achieve national public health objectives and build more resilient health systems.
This paper summarizes a literature review conducted in Pakistan on engaging the private sector for MNCH services during COVID-19.
The WHO’s Country Connector shares learnings from countries: in this new case study, we analyze how South Korea has learned from previous pandemics to strengthen its response to COVID-19.
Recently, a growing number of governments are exploring the best way to involve and engage the private sector to maximize their response to COVID-19 and to guarantee an equitable delivery of the COVID-19 vaccines for all.
The COVID-19 pandemic underscored the need for a multi-sectoral, “whole of society” approach to large-scale public health emergencies. While limited documentation exists on private sector participation in health security
This blog focuses on a preliminary learning agenda proposed by MOMENTUM that aims to capture lessons learned from partnerships with private sector actors, both NGOs and for-profits that have worked to build stronger and more
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------
With successive waves of COVID-19 battering low- and middle-income countries (LMICs), increasing attention has been directed to market and governance failures during the emergency response (1). These are most visible in LMICs
At a glance: Many LMICs – and notably countries participating in the COVAX facility – are preparing for the delivery of the COVID-19 vaccines. Supporting UHC principles of equity, quality, access and financial protection will be
This product is a collective effort by Anna Cocozza[1], Barbara O’Hanlon[2], Aurélie Paviza[1] and Meru Sheel[3], along with Kristopher Ansin[4], Grace Chee[5], David Clarke[1], Shalini Desai[6], Rebecca Fields[5], Somesh Kumar[3]
The COVID-19 pandemic has triggered a global surge in demand for health services. In response, all countries are striving to urgently increase their capacity to test, trace, and treat COVID-19 patients while also maintaining their
When it comes to the COVID-19 vaccination deployment, we did things wrong and missed the mark at a global level. This resulted in a highly inequitable vaccine deployment. Although more than 5.7 million doses have been administered
Within fragile, conflict-affected and vulnerable settings (FCVs), health system governance arrangements have evolved in response to conflict, creating a complex foundation for service provision. Service provision is often
This issue focuses on COVID response with a specific focus on Egypt, Iran, Iraq, and Morocco
